FIND is excited to be hosting a workshop entitled Bridging the Valley of Death – Keeping the Pipeline Alive for Novel Intervention Measures Against Poverty-Related Diseases.
WORKSHOP (WS 03): Sunday, 14 October 2018, 11:00 AM – 12:30 PM, Room 4 – Africa, Kosmos, Karl-Marx-Allee 131a, 10243 Berlin
Although infectious diseases remain a major health threat, the pipeline for novel intervention measures has come to a standstill. The situation has been further worsened by the profound increase of antimicrobial resistant pathogens and increasing occurrence of outbreaks with pandemic risk. Hence, better vaccines, drugs and diagnostics are urgently needed. This is particularly true for poverty-related diseases (PRDs) including the Big Three – tuberculosis, HIV/AIDS and malaria – and neglected diseases. It has become obvious that public and private funded institutions need to form partnerships to accelerate this process.
This workshop will discuss general strategies for, and more specific examples, of the clinical development of novel intervention measures and their optimisation to key populations, aimed at accomplishing this goal with a particular focus on PRDs.
European and Developing Countries Clinical Trials Partnerships (EDCTP)
Foundation for Innovative New Diagnostics (FIND)
Max Planck Society
Prof. Dr. Stefan H.E. Kaufmann Max Planck Institute for Infection Biology | Department of Immunology | Director | Germany
Dr. Michael Makanga European and Developing Countries Clinical Trials Partnership (EDCTP) | Executive Director | Netherlands
Dr Catharina Boehme, Foundation for Innovative New Diagnostics (FIND) | CEO | Switzerland
Ambassador Harald Braun, Germany’s former Permanent Representative to the United Nations
Dr. Mutsa Bwakura-Dangarembizi, University of Zimbabwe | Department of Paediatrics and Child Health | Senior Lecturer | Zimbabwe
Prof. Dr. med. Gérard Krause, Helmholtz Centre for Infection Research (HZI) | Department for Epidemiology | Head | Germany
Dr. Michael Makanga, European and Developing Countries Clinical Trials Partnership (EDCTP) | Executive Director | Netherlands
Dr. Umesh Shaligram, Serum Institute of India Pvt. Ltd. | Director Research & Development | India
Prof. Dr. Feiko ter Kuile, Liverpool School of Tropical Medicine | Chair in Tropical Epidemiology | United Kingdom